Acerus Pharmaceuticals Corporation ASP-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 07/30/21 EDT
0.04UNCH (UNCH)
Volume
10,000
52 week range
0.03 - 0.07

...

Loading . . .
  • Open0.04
  • Day High0.04
  • Day Low0.04
  • Prev Close0.04
  • 52 Week High0.07
  • 52 Week High Date02/10/21
  • 52 Week Low0.03
  • 52 Week Low Date11/24/20

Key Stats

  • Market Cap49.48M
  • Shares Out1,537.59M
  • 10 Day Average Volume79,314.29
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-

KEY STATS

  • Open0.04
  • Day High0.04
  • Day Low0.04
  • Prev Close0.04
  • 52 Week High0.07
  • 52 Week High Date02/10/21
  • 52 Week Low0.03
  • 52 Week Low Date11/24/20
  • Market Cap49.48M
  • Shares Out1,537.59M
  • 10 Day Average Volume79,314.29
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-1.19
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acerus Pharmaceuticals Corporation

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged in the development, manufacture, marketing and distribution of products with a focus on men's health, including urology, and women's health, including hormone replacement therapy and female sexual dysfunction. The Company markets Estrace in Canada, which is an oral, plant-derived 17-beta estradiol therapy for the relief of symptoms...
Ian Ihnatowycz
Chairman
Edward Gudaitis
President
Robert Motz
Chief Financial Officer
Philippe Savard
Vice President
Address
7025 Langer Drive, Suite 205
Mississauga, ON
L5N 0E8
Canada

Top Peers

SYMBOLLASTCHG%CHG
CPH
RX
ACST
Acasti Pharma Inc
0.4565-0.0015-0.3275%
OPNT
Opiant Pharmaceuticals Inc
16.12+0.52+3.33%
MRV
Nuvo Pharmaceuticals Inc
1.27+0.04+3.25%